Our multiplex IHC and Nanostring gene expression analyses demonstrated a lower number of both CD8+ and CD4+ T cells in FLCs than in NTL or the tumor-NTL interface but a relatively preserved number of Tregs in tumors. This evidence concerns the gene CD8A and neoplasm.